14:41:58 EDT Wed 12 Aug 2026
Enter Symbol
or Name
USA
CA



Jolt Health Inc (2)
Symbol JOLT
Shares Issued 16,728,754
Close 2026-07-31 C$ 0.035
Market Cap C$ 585,506
Recent Sedar+ Documents

Jolt Health closes $417,500 private placement

2026-08-12 09:26 ET - News Release

Subject: Jolt Health Inc. News Release Word Document

File: '\\swfile\EmailIn\20260812 054505 Attachment Final R Aug 2026.docx'

NATDOCS\95769150\V-1

For Immediate Release

JOLT HEALTH INC. ANNOUNCES CLOSING OF FINANCING

VANCOUVER, BC, CANADA (August 12, 2026) - Jolt Health Inc. ("JOLT" and or "the Company") (CSE:JOLT) (FSE: G1Q0) announces it has closed its previously announced non-brokered private placement. The Company accepted subscriptions for 8,350,000 units at a price of $0.05 per unit (the "Units") for gross proceeds of $417,500.

Pursuant to the terms of the Financing, each Unit consists of one common share in the equity of the Company and one common share purchase warrant (a "Warrant"). Each Warrant entitles the holder to purchase one additional common share of the Company at a price of $0.10 per share for a period of two (2) years from the closing of the Financing, subject to the option of the Company to accelerate the expiry date in the event that its shares trade at $0.25 or more for 10 consecutive days.

The Company paid $4,574.96 in cash and issued 91,499 broker warrants to a qualified finder. The broker warrants are exercisable at a price of $0.05 per share for a period of two (2) years from the closing of the Financing, subject to the option of the Company to accelerate the expiry date in the event that its shares trade at $0.25 or more for 10 consecutive days.

Securities issued are subject to trading restrictions until December 13, 2026.

Jolt intends to use the net proceeds of the Offering for general working capital.

About Jolt Health Inc.

Jolt Health Inc. (CSE - JOLT) is a life sciences company focused on healthcare, biotechnology and artificial intelligence.

For further information, please contact:

Gerald Tritt, CEO

Investor Relations

Telephone: 1 (604) 343-2977

E-mail: info@jolt-health.com

www.jolt-health.com

Neither the Canadian Securities Exchange nor its Regulation Services Provider (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this release.

Forward Looking Statements

Certain information set forth in this news release may contain forward-looking statements that involve substantial known and unknown risks and uncertainties. All statements other than statements of historical fact are forward-looking statements, including, without limitation, statements regarding future financial position, business strategy, use of proceeds, corporate vision, proposed acquisitions, partnerships, joint-ventures and strategic alliances and co-operations, budgets, cost and plans and objectives of or involving the Company. Such forward-looking information reflects management's current beliefs and is based on information currently available to management. Often, but not always, forward-looking statements can be identified by the use of words such as "plans", "expects", "is expected", "budget", "scheduled", "estimates", "forecasts", "predicts", "intends", "targets", "aims", "anticipates", "may" or "believes" or variations (including negative variations) of such words and phrases or may be identified by statements to the effect that certain actions "may", "could", "should", "would", "might" or "will" be taken, occur or be achieved. A number of known and unknown risks, uncertainties and other factors may cause the actual results or performance to materially differ from any future results or performance expressed or implied by the forward-looking information. These forward-looking statements are subject to numerous risks and uncertainties, certain of which are beyond the control of the Company including, but not limited to, the impact of general economic conditions and industry conditions. Readers are cautioned that the assumptions used in the preparation of such information, although considered reasonable at the time of preparation, may prove to be imprecise and, as such, undue reliance should not be placed on forward-looking statements. The Company does not assume any obligation to update or revise its forward-looking statements, whether as a result of new information, future events, or otherwise, except as required by securities laws.

© 2026 Canjex Publishing Ltd. All rights reserved.